Madrigal stock slumped and was halted Thursday before the FDA approved its liver disease treatment, now called Rezdiffra.
Madrigal Stock Soars More Than 20% After FDA Approved First In MASH Treatment
Mar 14, 2024
Stay Ahead of the Curve: Subscribe Now to Receive Instant Breaking News Alerts Directly to Your Inbox!
- Latest
- Popular
